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Abstract
Background: The potato is one of the most common types of genetically modified (GM) food.
However, there are no published data evaluating the impact of genetic manipulations on the
allergenicity of GM potatoes. To compare the allergenicity of GM potatoes with that of wild-type
potatoes using in vivo and in vitro methods in adult allergy patients sensitized to potatoes.
Methods:  A total of 1886 patients with various allergic diseases and 38 healthy controls
participated in the study. Skin-prick testing and IgE-ELISA were carried out with extracts prepared
from wild-type and GM potatoes. An ELISA inhibition test was used to confirm the binding
specificity. IgE-binding components in extracts from the two types of potato were identified by
SDS-PAGE and IgE-immunoblotting. The effects of digestive enzymes and heat on the allergenicity
of the extracts was evaluated by preincubating the potatoes with or without simulated gastric and
intestinal fluids in the absence or presence of heat.
Results: Positive responses (ratio of the wheal size induced by the allergen to that induced by
histamine (A/H) ≥ 2+) to wild-type or GM potato extracts, as demonstrated by the skin-prick test,
were observed in 108 patients (5.7%). Serum-specific IgE was detected in 0–88% of subjects who
tested positively. ELISA inhibition tests indicated significant inhibition when extract from each type
of potato was added. IgE-immunoblot analysis demonstrated the presence of 14 IgE-binding
components within the wild-type potato and 9 within the GM potato. Furthermore, a common 45-
kDa binding component that yielded similar IgE-binding patterns was noted in more than 80% of
the reactions using sera from patients sensitized to wild-type or GM potato. Exposure to simulated
gastric fluid and heat treatment similarly inhibited IgE binding by extracts from wild-type and GM
potatoes, whereas minimal changes were obtained following exposure of the extracts to simulated
intestinal fluid.
Conclusion: Our results strongly suggest that genetic manipulation of potatoes does not increase
their allergenic risk. The sensitization rate of adult allergy patients to both types of extract was
5.7%, and a common major allergen (45 kDa) was identified.
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Background
Food-induced allergic reactions are responsible for a vari-
ety of symptoms involving the skin, gastrointestinal tract,
and respiratory tract, and proceed through IgE- and non-
IgE-mediated mechanisms. The major foods responsible
for food-induced allergic reactions are milk, eggs, peanuts,
fish, and tree nuts in children, and peanuts, tree nuts, fish,
and shellfish in adults [1]. There are some reports in the
literature on allergic reactions to potatoes; for example, a
child developed urticaria and angioedema after eating a
potato [2,3], bronchial asthma was induced in an individ-
ual while peeling a raw potato [4], and anaphylaxis devel-
oped in response to raw potatoes [5]. Furthermore,
potatoes have been found to cross-react with birch pollen,
fruits, and latex [6,7].
Agricultural biotechnology has tremendous implications
for both agriculture and the general public. Insect-resist-
ant corn and herbicide-tolerant soybeans are grown on
30–50% of the total acreage planted with these crops in
North America [8]. Previous studies comparing the aller-
genicity of wild-type and genetically modified (GM) corn
demonstrated that the allergic risk was not increased after
genetic manipulation [9-11]. In Korea, potato, soybean,
and corn are the most commonly exposed GM foods;
however, to date, there are no reports on the allergenic
risk of GM potatoes.
In this study, the sensitization rates of adult allergy
patients in response to wild-type and GM potatoes were
evaluated by skin-prick test and ELISA (enzyme linked
immunosorbent assay). SDS-PAGE (sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis) and IgE-immu-
noblotting were carried out to identify the major allergens
present in the potato extracts. To evaluate the effects of
digestive enzymes and heat on the allergenicity of the two
types of potato, the extracts were preincubated with or
without simulated gastric and intestinal fluids in the pres-
ence or absence of heat.
Methods
Subjects
Sensitization rates to the two potato extracts were evalu-
ated in 1886 allergy patients and in 38 healthy non-atopic
subjects. The participants, who ranged in age from 15 to
65 years, were enrolled in the study by the Department of
Allergy and Rheumatology, Ajou University School of
Medicine, Suwon, Korea. The GM potato, carrying the
neomycin phosphotransferase II (NPTII) and phosphi-
nothricin acetyltransferase (PAT) genes (Table 1), was
provided by ChonBuk National University, Chunju,
Korea. The wild-type potato was produced in Korea. From
January 2004 to October 2004, 1886 patients admitted to
the hospital for the treatment of various allergic diseases,
including asthma, allergic rhinitis, and food and drug
allergy, were skin-prick tested with common inhalant
allergens and with extracts from GM and wild-type pota-
toes. In the skin-prick tests, 50 common inhalant aller-
gens, 30 food allergens, and the potato extracts were
applied using 26-gauge needles to the backs of the
patients. The results were read 15 min later. A positive
reaction was defined as a mean wheal diameter of ≥3 mm.
The size of the wheal produced by each antigen or by the
positive control histamine was expressed in terms of max-
imum diameter and vertical length at the midportion of
the maximal length. Skin reactivity was expressed as the
ratio of the wheal size induced by the allergen and that
induced by histamine (A/H). The data were recorded in
accordance with the recommendations of the Standardi-
zation Committee of the Northern Society of Allergology
[12]. An A/H of 0.1–1 and an erythema diameter of <21
mm was assigned a reactivity of 1+. An A/H of 0.1–1 and
erythema >21 mm was assigned a reactivity of 2+. An A/H
in the range of 1–2 was recorded as a reactivity of 3+. For
an A/H of 2–3, reactivity was 4+, and for an A/H >3 reac-
tivity was 5+. A positive responder was defined as a subject
who demonstrated a response >2+ on the skin-prick test.
This study was reviewed by the institutional review board
of Ajou University Medical Center, Suwon, Korea.
Preparation of extracts from wild-type and GM potatoes
Extracts were prepared from wild-type and GM potatoes
using phosphate-buffered saline (PBS; pH 7.5, 1:10 w/v),
kept at 4°C overnight, and then centrifuged at 12,000–
15,000 rpm for 20 min. The supernatant was dialyzed (the
cutoff molecular weight was 6000 Da; Spectrum Medical
Industries, Houston, TX, USA) against 4 l of PBS at 4°C for
72 h, and the resultant fluid was stored at -20°C until
ELISA, ELISA inhibition testing, and immunoblot analy-
ses were carried out. For the skin-prick test, extract was
mixed with sterile glycerin at a ratio of 1:1. To evaluate the
effects of digestive enzymes, simulated gastric fluid (SGF;
471 U pepsin/mg; Sigma Chemical Co., St. Louis, MO,
USA) and simulated intestinal fluid (SIF; pancreatin;
Sigma) were preincubated with the extracts in the pres-
ence or absence of heat.
ELISA for specific IgE antibodies to potato extracts
The presence of specific IgE antibodies to the two types of
extract was determined by ELISA, as previously described
[13]. Microtiter plates (Corning, NY) were coated with
Table 1: Primer sequences of inserted PAT and NPT genes.
Primer sequence
PAT 2587U 5'-TCG TCA ACC ACT ACA TCG AGA-3
PAT 2893L 5'-ATG ACA GCG ACC ACG CTC TT-3'
NBT 3161U 5'-AGA AAG TAT CCA TCA TGG CTG A-3'
NBT 3574L 5'-ATA CCG TAA AGC ACG AGG AAG-3'Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
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100 µl of extract (GM or wild-type, 10 µg/ml)/well and
kept overnight at 4°C. Each well was washed three times
with 0.05% PBS-Tween (PBST), and the remaining bind-
ing sites were blocked by incubation with 10% fetal
bovine serum (FBS)-PBS for 1 h at room temperature. The
wells were then incubated for 2 h at room temperature
with either 50 µl of the patients' sera or the control sera,
both at 50% dilution. The control sera were from the 38
healthy controls who had tested negative in the skin-prick
tests to the common inhalant and food allergens and to
potatoes. The wells were washed three times with PBST,
1:1000 v/v biotin-labeled goat anti-human IgE antibody
(Vector Lab, Burlingame, CA, USA) was added to each
well, and the plates were incubated for 1 h at room tem-
perature. After another washing, 100 µl of 1:1000 v/v
streptavidin-peroxidase (Sigma) was added, the plates
were incubated for 30 min, and the wells were washed
again.
The colorimetric reaction was developed with a TMB
(3,3',5,5'-tetramethylbenzidine) substrate solution for 15
min at room temperature. The reaction was stopped by
the addition of 100 µl of 2 N sulfuric acid, and absorbance
was read at 450 nm using an automated microplate reader
(Benchmark; Bio-Rad Laboratories, Hercules, CA, USA).
All assays were carried out in duplicate. Positive cutoff val-
ues were determined from the mean plus two standard
deviations of the absorbance values of the 38 healthy con-
trols.
ELISA inhibition test
The specificity of IgE binding to the potato extracts was
tested and the allergenic potency of the GM and wild-type
potato extracts was analyzed by a competitive ELISA inhi-
bition test. Sera from four patients with high levels of spe-
cific IgE binding were pooled, preincubated overnight at
4°C with five concentrations (1–100 µg/ml) of either Der-
matophagoides pteronyssinus or extract from GM or wild-
type potatoes, and then incubated for 12 h in microtiter
plates coated with extracts from the two types of potato.
The same steps were followed as in the ELISA. As a control,
samples were preincubated with equal volumes of PBS
(pH 7.5) instead of house dust mite or potato extracts. The
percentage of inhibition of serum IgE binding was
expressed as: 100 - (absorbance of the samples preincu-
bated with allergens/absorbance of the samples preincu-
bated with PBS) × 100.
SDS-PAGE and immunoblot analysis
SDS-PAGE and immunoblot analysis were carried out
under reducing conditions according to previously
described methods [13]. Extracts from the two potatoes
were mixed with sample buffer (Tris-HCl 31 mmol/l, 10%
glycerol, 1% SDS, 0.0025% bromophenol blue, 2.5% β-
mercaptoethanol, pH 6.8) and heated in boiling water for
5 min. Standard markers (4–250 kDa; Novex, San Diego,
CA, USA) and the extracts were loaded on a 4–20% Tris-
glycine gel (Novex). Electrophoresis was done with a
Novex X cell™ Mini cell for 90 min at 125 V. The gel was
fixed and stained with Coomassie brilliant blue. For
immunoblotting, proteins were transferred onto a polyvi-
nylidene difluoride membrane (PVDF; Millipore Co.,
Bedford, MA, USA) in transfer buffer (Tris-base 25 mmol/
l, glycine 193 mmol/l, and methanol 20%) using a Bio-
Rad transfer apparatus set at 200 mA for 90 min. The blot-
ted PVDF membrane was sliced into 4-mm widths and
then incubated in 5% skim milk in Tris-buffered saline
(TBS)-Tween (TBST) for 1 h to block nonspecific binding
to the membranes. Each membrane slice was incubated
overnight at 4°C with patient or control sera diluted 1:2
v/v with 3% skim milk in TBST, and then washed with
0.1% TBST for 30 min. Subsequently, the membranes
were incubated with goat anti-human IgE conjugated with
alkaline phosphatase (Sigma) for 1 h at room tempera-
ture, washed with TBST, and then developed with BCIP/
NBT alkaline phosphatase substrate (Sigma).
Effect of simulated gastric and intestinal fluid on the IgE-
binding components
Crude extracts were prepared from GM and wild-type
potatoes and then heated at 100°C for 5 min. The intrin-
sic digestibility of the extracts and the digestibility of
extracts preheated and incubated in SGF or SIF were exam-
ined as previously described [14]. Briefly, SGF digestibility
Table 2: Specific IgE binding, stratified by the results of skin-prick testing, to extracts of wild-type and GM potatoes.
A/H ratio Wild-type potato GM potato
2+ 3+ 4+ 5+ 6+ 2+ 3+ 4+ 5+ 6+
Skin-prick test result n (%) 38 (35.2) 48 (44.5) 12 (11.1) 7 (6.4) 3 (2.8) 36 (33.3) 51 (47.2) 13 (12) 6 (5.6) 2 (1.9)
sIgE (%) to Wild 13/23 (57) 18/28 (64) 5/8 (63) 2/4 (50) 0/2 (0) 8/19 (42) 17/31 (55) 6/8 (75) 1/5 (20) 0/2 (0)
GM 10/23 (44) 16/28 (57) 5/8 (63) 1/4 (25) 0/2 (0) 11/19 (58) 18/31 (58) 7/8 (88) 3/5 (60) 1/2 (50)
Positive skin-prick test response (≥2+): 108/1886 for wild-type and genetically modified (GM) potato. A/H ratio: the ratio of the size of the wheal 
induced by allergen on allergic skin-prick test to that induced by histamine; N: number of subjects positive to skin-prick test for wild-type and GM 
potato; sIgE: prevalence of serum specific IgE antibody to wild-type and GM potato (number of subjects with positive serum specific IgE/number of 
subjects tested in each response group according to the skin-prick test using potato extract).Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
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was analyzed by dissolving 680 µg of naïve crude extract
or preheated extract in 200 µl of prewarmed 100 mmol
HCl/l (pH 1.2) and 30 mmol NaCl/l containing 0.32%
(w/v) pepsin A (Sigma). Digestion was conducted at 37°C
with continuous shaking, and aliquots of the digested
solution (20 µl) were withdrawn at 0, 0.5, and 60 min.
These aliquots were quickly mixed with 26 µl of sample
buffer (containing 2.5% 2-mercaptoethanol and 1% SDS)
and 6.0 µl of Na2CO3 (200 mmol/l). The mixture was
then boiled for 5 min and stored at -20°C until further
analysis. To evaluate the effects of SIF, 680 µg of the naïve
crude extract or the preheated extract were dissolved in
260 µl of prewarmed intestinal control solution (0.05 M
KH2SO4, pH 6.8) containing 1.0% (w/v) pancreatin (pan-
creatin USP; Sigma). This solution was incubated at 37°C
with continuous shaking. Aliquots (26 µl) were with-
drawn at 1, 90, and 240 min, mixed with 26 µl of sample
buffer (containing 2.5% 2-mercaptoethanol and 1%
SDS), and then boiled for 5 min. SDS-PAGE (12%) and
IgE-immunoblot analysis were then carried out as
described above.
Results
Allergy skin-prick test and specific IgE to wild-type and GM 
potatoes
During the one-year study, 108 (5.7%) of the 1886
patients had an A/H score >2+ in response to the skin-
prick test using extracts from GM and wild-type potatoes.
All of the subjects who reacted positively to the GM potato
also had positive responses to the wild-type potato, as
seen in Table 2. House-dust mites are the most common
aeroallergen in Korea, followed by weed, tree, and grass
pollens [15], but, based on allergy skin-prick testing, no
specific antigen showing cross-reactivity with potato pro-
teins has been identified. ELISA using sera from subjects
with a positive skin prick test showed that the prevalence
Specific IgE binding to extracts of wild-type and GM potatoes, as determined by ELISA, vs. the A/H ratio of the potato Figure 1
Specific IgE binding to extracts of wild-type and GM potatoes, as determined by ELISA, vs. the A/H ratio of the potato. A/H: the 
ratio of the size of the wheal induced by allergen on allergic skin-prick test to that induced by histamine. N: number of subjects 
in each response group according to the skin-prick test using potato extract. Positive cutoff values were determined from the 
mean plus two standard deviations (M + 2SD) of the absorbance values of the 38 healthy controls.Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
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of specific IgE to extracts of wild-type and GM potatoes
ranged from 0–88%, with 57 and 58% (13 of 23 and 11
of 19, respectively) having a 2+ reaction, 64 and 58% (18
of 28 and 18 of 31, respectively) with a 3+ reaction, 63
and 88% (5 of 8 and 7 of 8, respectively) having a 4+ reac-
tion, and 50 and 60% (2 of 4 and 1 of 2, respectively) with
a 5+ reaction, 0 and 50% (0 and 1 of 2, respectively) with
a 6+ reaction. (Table 2, Fig. 1).
ELISA inhibition test
The ELISA inhibition test showed significant dose-
dependent inhibition for wild-type and GM potato
extracts. In addition, the two extracts had similar poten-
cies. By contrast, minimal inhibition was noted using D.
pteronyssinus. Figure 2 shows the ELISA inhibition test by
the addition of extracts from wild-type and GM potato
and Dermatophagoides pteronyssinus. The same pooled sera
from patients sensitized to potatoes were used (A: wild-
type potato; B: GM potato).
SDS-PAGE and IgE-immunoblot analysis
The IgE-binding components within the wild-type and
GM potatoes were compared using the sera of eight indi-
viduals with high specific IgE levels and sera pooled from
the controls. The latter was derived from 10 patients who
responded negatively to the two potato extracts on the
skin-prick test. Three components (45, 34, and 26 kDa)
were noted in >50% and 11 components (78, 72, 64, 36,
35, 25, 23, 22, 20, 19, and 14 kDa) in 33% of patients sen-
sitized to wild-type potato. One component (45 kDa) was
noted in 88% and eight components (78, 64, 35, 26, 25,
23, 22, and 14 kDa) in <50% of patients sensitized to GM
potato. Thus, the 45-kDa band present in serum was the
most frequently bound (>80%) by extracts from wild-type
and GM potatoes (Fig. 3).
Effect of digestive enzymes on extracts of GM and wild-
type potatoes
Figures 4, 5, and 6 demonstrate the changes both in the
proteins, as seen on SDS-PAGE, and in the IgE-binding
components of extracts from wild-type and GM potatoes
after SGF or SIF treatments in the presence or absence of
heating. A combination of SGF and heat treatment
resulted in the disappearance of the protein bands and the
IgE-binding components in extracts from wild-type and
GM potatoes, while minimal changes were noted with SIF
treatment alone.
Discussion
The results of this study demonstrate that the prevalence
of positive skin-prick tests to extracts from wild-type and
GM potatoes was 5.7% in our population of adult allergy
patients. Serum-specific IgE antibodies were detected
among the positive responders. The 45-kDa allergenic
band was the most frequently bound (>80%) by the two
types of extract, and ELISA inhibition studies suggested
Percent inhibition of IgE-ELISA by the addition of: extract from wild-type potato (● ), GM potato extract (❍ ), and Dermatopha- goides pteronyssinus () Figure 2
Percent inhibition of IgE-ELISA by the addition of: extract from wild-type potato (● ), GM potato extract (❍ ), and Dermatopha-
goides pteronyssinus (). Sera from patients sensitized to potatoes were used. A: wild-type potato; B: GM potato.Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
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that they had similar potencies. Recent investigations to
evaluate the allergic risks of GM corn and soybean dem-
onstrated that allergenicity did not increase after genetic
manipulation of wild-type corn [11] and soybean [9].
Similarly, our study showed that the genetic manipulation
of potatoes, which are one of the most common sources
of food allergens in Korea, did not enhance their aller-
genic risk, as evaluated using in vivo and in vitro methods.
GM crops currently on the market have been thoroughly
assessed for safety according to the guidelines developed
by the World Health Organization [16] and the Food and
Agriculture Organization of the United Nations [17]. In
addition, the potential allergenicity of newly introduced
proteins must be assessed in all foods produced through
agricultural biotechnology, and the FAO [18] and WHO
have developed a rigorous approach for this assessment.
The  NPTII  gene introduced in the potato used in this
study encodes an enzyme that confers resistance to
aminoglycoside antibiotics and was isolated from the
prokaryotic transposon Tn5 [19]. The PAT  gene was
obtained from the aerobic soil bacterium Streptomyces viri-
dochromogenes. If the gene source is bacterial, specific and
targeted serum screenings are not necessary because bacte-
rial proteins are rarely allergenic, due to the low exposure
levels and lack of allergic sensitization to these proteins
[8]. Furthermore, previous studies have confirmed that
ingestion of genetically engineered plants expressing
NPTII does not pose any safety concerns [20,21]. Herouet
et al. [22] found that PAT proteins do not possess the char-
acteristics associated with food toxins or allergens, i.e.,
they have no sequence homology with any known aller-
gens or toxins. These findings suggest that an increase in
the allergenic risk of a GM potato is unlikely.
A few studies have identified IgE-binding components
within potato extracts. Wahl et al. [23] reported four (16,
30, 45, and 65) IgE-binding components, which were
detected by immunoblotting using sera from 12 patients
with IgE-mediated hypersensitivity reactions to potatoes.
Four major potato allergens, Sol t 1 (43 kDa), 2 (21 kDa),
3 (21 kDa), and 4 (16 kDa), were identified in children
[24,25]. Furthermore, several studies have shown that
allergy to natural rubber latex is associated with cross-
reactivity to potatoes and tomatoes [7,26]. In our study of
the Korean population, only one allergenic protein (45
kDa) could be identified as the major allergen, and it was
present in extracts from wild-type and GM potatoes.
Moreover, this protein may be the same one identified in
a previous investigation [23].
SDS-PAGE of proteins (A) and IgE-binding components (B) present in wild-type and GM potato extracts, as measured in sensi- tized patients Figure 3
SDS-PAGE of proteins (A) and IgE-binding components (B) present in wild-type and GM potato extracts, as measured in sensi-
tized patients. W: wild-type potato extracts; G: GM potato extracts. M: marker; lanes 1–8: sensitized subjects; lane 9: normal 
control; lane 10: buffer control.Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
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Proteolytic stability is a useful criterion in assessing the
allergenic potential of food allergens. The FAO/WHO [18]
decision-tree approach advocates the use of resistance to
proteolysis with pepsin as a comparative measure of
digestive stability for proteins introduced into food
through agricultural biotechnology. In the current study,
we demonstrated that SGF and heat treatment substan-
tially suppressed the activity of IgE-binding components
in wild-type and GM potato extracts, while minimal
changes were noted with SIF treatment alone.
Conclusion
We report that the sensitization rate of patients to wild-
type and GM potato extracts was 5.7%, and the prevalence
of specific IgE to these extracts in the sera of subjects with
a positive skin-prick test was similar. An ELISA inhibition
test showed significant dose-dependent inhibition by GM
and wild-type potato extracts, and the two extracts had
similar potencies. A 45-kDa band was identified as the
most frequently bound by both extracts. Our results
strongly suggest that genetic manipulation of potatoes
using antibiotic resistance and herbicide tolerance genes
does not increase their allergenic risk.
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Effect of boiling on wild-type (A) and GM (B) potato allergenicity, analyzed by IgE-immunoblotting Figure 4
Effect of boiling on wild-type (A) and GM (B) potato allergenicity, analyzed by IgE-immunoblotting. F: Fresh potato extract; H: 
heated extract. Lanes 1–5: sensitized subjects; lanes 6 and 7: normal control; lane 8: buffer control.Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
Page 8 of 10
(page number not for citation purposes)
Effect of simulated gastric fluid (SGF) treatment on extracts from wild-type and GM potatoes, as determined by SDS-PAGE (A,  B), and on IgE-binding components present in the extracts (C, D) Figure 5
Effect of simulated gastric fluid (SGF) treatment on extracts from wild-type and GM potatoes, as determined by SDS-PAGE (A, 
B), and on IgE-binding components present in the extracts (C, D). A, C: extracts from wild-type potato; B, D: extracts from 
GM potato; M: marker; lanes 1–7: incubation for 0 s, 30 s, 1 min, 10 min, 30 min, 1 h, and 1.5 h with sera pooled from five 
patients. pH of SGF: ca. 1.2.Clinical and Molecular Allergy 2006, 4:10 http://www.clinicalmolecularallergy.com/content/4/1/10
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